In serum-starved HUVECs, Nicorandil at 100 µmol/L induced time-dependent Akt serine-473 phosphorylation, reaching a maximum 3.0-fold increase. In HL-1 cells, preincubation with Nicorandil at 30 μM, 50 μM or 100 μM for 90 min before L-arginine addition activated the NO accumulation rate. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Time-Dependent Akt Phosphorylation in Serum-Starved HUVECs
Cell-based study · serum-starved HUVECs [1]
Serum-starved HUVECs were stimulated with Nicorandil at 100 µmol/L. Nicorandil induced time-dependent Akt serine-473 phosphorylation, with a maximum 3.0-fold increase.
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 µmol/L
- Exposure duration
- for the indicated time intervals
- Method
- stimulated
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Nicorandil
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Cell culture (S32); Results > Nicorandil activates the PI3K/Akt and ERK pathways in vascular endothelial cells (S83, S84); Figure 8 legend (S149)
Akt serine-473 phosphorylation: Akt serine-473 phosphorylation; comparator: control (no drug) — Results > Nicorandil activates the PI3K/Akt and ERK pathways in vascular endothelial cells (S84)
Nitric Oxide Accumulation After Preincubation in Cardiac Cells
Cell-based study · HL-1 cells [2]
HL-1 cells were preincubated with Nicorandil at 30 μM, 50 μM or 100 μM for 90 min before L-arginine addition. This treatment activated the NO accumulation rate.
Literature-Reported Treatment Conditions
- Treatment concentration
- 30 μM, 50 μM or 100 μM
- Exposure duration
- preincubated for 90 min
- Method
- added in preincubation before the addition of L-arginine
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Nicorandil
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and methods > NO production (S27); Results > NO and nicorandil (S93, S94, S95); Fig 3 legend (S160, S161)
NO production rate: NO production rate; comparator: the rate measured in the absence of nicorandil (100%) — Results > NO and nicorandil (S94, S95); Fig 3 legend (S160, S161)